These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 7872761)

  • 1. Growth of Cryptococcus neoformans in presence of L-dopa decreases its susceptibility to amphotericin B.
    Wang Y; Casadevall A
    Antimicrob Agents Chemother; 1994 Nov; 38(11):2648-50. PubMed ID: 7872761
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Melanization of Cryptococcus neoformans and Histoplasma capsulatum reduces their susceptibilities to amphotericin B and caspofungin.
    van Duin D; Casadevall A; Nosanchuk JD
    Antimicrob Agents Chemother; 2002 Nov; 46(11):3394-400. PubMed ID: 12384341
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cryptococcus neoformans/Cryptococcus gattii species complex melanized by epinephrine: Increased yeast survival after amphotericin B exposure.
    Brilhante RSN; Rocha MGD; Oliveira JS; Pereira-Neto WA; Guedes GMM; Cordeiro RA; Sidrim JJC; Rocha MFG; Castelo-Branco DSCM
    Microb Pathog; 2020 Jun; 143():104123. PubMed ID: 32169493
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Budding of melanized Cryptococcus neoformans in the presence or absence of L-dopa.
    Nosanchuk JD; Casadevall A
    Microbiology (Reading); 2003 Jul; 149(Pt 7):1945-1951. PubMed ID: 12855745
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of Pimenta pseudocaryophyllus (Gomes) L. R. Landrum, on melanized and non-melanized Cryptococcus neoformans.
    de Fátima Lisboa Fernandes O; Costa CR; de Souza Lino Junior R; Vinaud MC; Hasimoto E Souza LK; de Paula JA; do Rosário Rodrigues Silva M
    Mycopathologia; 2012 Dec; 174(5-6):421-8. PubMed ID: 22932958
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of melanin upon susceptibility of Cryptococcus to antifungals.
    Ikeda R; Sugita T; Jacobson ES; Shinoda T
    Microbiol Immunol; 2003; 47(4):271-7. PubMed ID: 12801064
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Susceptibility of melanized and nonmelanized Cryptococcus neoformans to the melanin-binding compounds trifluoperazine and chloroquine.
    Wang Y; Casadevall A
    Antimicrob Agents Chemother; 1996 Mar; 40(3):541-5. PubMed ID: 8851567
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiphagocytic protein 1 increases the susceptibility of Cryptococcus neoformans to amphotericin B and fluconazole.
    Ghaffar M; Orr C; Webb G
    PLoS One; 2019; 14(12):e0225701. PubMed ID: 31800598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sterol compositions and susceptibilities to amphotericin B of environmental Cryptococcus neoformans isolates are changed by murine passage.
    Currie B; Sanati H; Ibrahim AS; Edwards JE; Casadevall A; Ghannoum MA
    Antimicrob Agents Chemother; 1995 Sep; 39(9):1934-7. PubMed ID: 8540694
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of L-DOPA on Cryptococcus neoformans growth and gene expression.
    Eisenman HC; Chow SK; Tsé KK; McClelland EE; Casadevall A
    Virulence; 2011; 2(4):329-36. PubMed ID: 21705857
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amphotericin B resistant isolates of Cryptococcus neoformans without alteration in sterol biosynthesis.
    Joseph-Horne T; Loeffler RS; Hollomon DW; Kelly SL
    J Med Vet Mycol; 1996; 34(3):223-5. PubMed ID: 8803806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Melanization affects susceptibility of Cryptococcus neoformans to heat and cold.
    Rosas AL; Casadevall A
    FEMS Microbiol Lett; 1997 Aug; 153(2):265-72. PubMed ID: 9271852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of voriconazole on Cryptococcus neoformans.
    van Duin D; Cleare W; Zaragoza O; Casadevall A; Nosanchuk JD
    Antimicrob Agents Chemother; 2004 Jun; 48(6):2014-20. PubMed ID: 15155193
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined in vitro effect of amphotericin B and rifampin on Cryptococcus neoformans.
    Fujita NK; Edwards JE
    Antimicrob Agents Chemother; 1981 Jan; 19(1):196-8. PubMed ID: 7018384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Susceptibility of Cryptococcus neoformans biofilms to antifungal agents in vitro.
    Martinez LR; Casadevall A
    Antimicrob Agents Chemother; 2006 Mar; 50(3):1021-33. PubMed ID: 16495265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thermal death potentiation by amphotericin B in Cryptococcus neoformans and its dependence on pre-incubation temperature.
    Madeira-Lopes A
    J Med Vet Mycol; 1986 Feb; 24(1):35-40. PubMed ID: 3517277
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pneumocandin L-743,872 enhances the activities of amphotericin B and fluconazole against Cryptococcus neoformans in vitro.
    Franzot SP; Casadevall A
    Antimicrob Agents Chemother; 1997 Feb; 41(2):331-6. PubMed ID: 9021188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of ketoconazole and amphotericin B on encapsulated and non-encapsulated strains of Cryptococcus neoformans.
    Smith D; McFadden HW; Miller NG
    Antimicrob Agents Chemother; 1983 Dec; 24(6):851-5. PubMed ID: 6318662
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The copper interference with the melanogenesis OF Cryptococcus neoformans.
    Mauch RM; Cunha Vde O; Dias AL
    Rev Inst Med Trop Sao Paulo; 2013; 55(2):117-20. PubMed ID: 23563765
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Melanization of Cryptococcus neoformans reduces its susceptibility to the antimicrobial effects of silver nitrate.
    García-Rivera J; Casadevall A
    Med Mycol; 2001 Aug; 39(4):353-7. PubMed ID: 11556765
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.